Study in Patients With COPD

Dey690 enrolled

Overview

The purpose of this study is to determine the efficacy and safety of the investigational drug in the treatment of COPD in comparison with a placebo.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

690

Conditions

COPD

Interventions

Formoterol FumarateDRUG

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Medical diagnosis of COPD * Current or prior history of cigarette smoking Exclusion Criteria: * Medical diagnosis of asthma * Chest x-ray (CXR) prior to Day 1 diagnostic of significant disease other than COPD * Significant condition or disease other than COPD

Locations (68)

Outcomes

Primary Outcomes

Measure of lung function

Secondary Outcomes

Change in lung function, as well as vital signs

Physical Exam results, Adverse Event reporting, etc

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Research Site

Bessemer, Alabama, United States

Research Site

Birmingham, Alabama, United States

Research Site

Phoenix, Arizona, United States

Research Site

Tuscon, Arizona, United States

Research Site

Tuscon, Arizona, United States

Research Site

Tuscon, Arizona, United States

Research Site

Buena Park, California, United States

Research Site

Encinitas, California, United States

Research Site

Huntington Beach, California, United States

Research Site

Los Angeles, California, United States

...and 58 more locations